Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-22 Sale |
2023-06-26 5:11 pm |
Roivant Sciences Ltd. | ROIV | VIKING GLOBAL INVESTORS LP Ott David C. HALVORSEN OLE ANDREAS Shabet Rose Sharon Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Parent GP LLC 10% Owner |
13,000,000 | $9.9 | $128,700,000 | 12,884,307 (Indirect) |
View |
| 2023-06-22 Sale |
2023-06-26 5:10 pm |
Roivant Sciences Ltd. | ROIV | VIKING GLOBAL PERFORMANCE LLC Ott David C. HALVORSEN OLE ANDREAS Shabet Rose Sharon Viking Global Equities Master Ltd. Viking Global Equities II LP Viking Long Fund Master Ltd. Viking Long Fund GP LLC 10% Owner |
13,000,000 | $9.9 | $128,700,000 | 12,884,307 (Indirect) |
View |
| 2023-06-22 Sale |
2023-06-26 4:05 pm |
Roivant Sciences Ltd. | ROIV | Sumitomo Chemical Co. Ltd. Sumitomo Pharma Co. Ltd. 10% Owner |
15,116,277 | $8.6 | $129,999,982 | 71,251,083 (Indirect) |
View |
| 2023-06-09 Sale |
2023-06-13 9:31 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
43,893 | $9.93 | $435,857 | 198,582 (Direct) |
View |
| 2023-06-07 Sale |
2023-06-09 9:32 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
299,585 | $9.91 | $2,968,875 | 31,605,849 (Direct) |
View |
| 2023-05-23 Sale |
2023-05-25 9:30 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
415 | $9.85 | $4,088 | 16,298,537 (Direct) |
View |
| 2023-05-09 Sale |
2023-05-11 9:33 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
238,724 | $9.23 | $2,203,423 | 16,298,952 (Direct) |
View |
| 2023-05-04 Sale |
2023-05-08 9:30 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
150,044 | $8.557 | $1,283,925 | 32,460,790 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 9:30 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
288,989 | $8.3987 | $2,427,129 | 49,058,218 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 9:30 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
77,736 | $8.5481 | $664,492 | 1,715,656 (Direct) |
View |
| 2023-04-26 Sale |
2023-04-28 9:35 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
230,788 | $8.5622 | $1,976,057 | 2,898,294 (Direct) |
View |
| 2023-04-26 Sale |
2023-04-28 9:35 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
222,243 | $8.5456 | $1,899,191 | 49,803,751 (Direct) |
View |
| 2023-03-20 Sale |
2023-03-22 9:00 pm |
Roivant Sciences Ltd. | ROIV | SVF Investments (UK) Ltd SoftBank Vision Fund L.P. SVF Holdings (UK) LLP SB INVESTMENT ADVISERS (UK) LTD 10% Owner |
12,000,000 | $8 | $96,000,000 | 83,031,667 (Indirect) |
View |
| 2023-03-01 Sale |
2023-03-03 9:00 pm |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,912 | $8.08 | $15,449 | 223,347 (Direct) |
View |
| 2023-02-22 Sale |
2023-02-22 5:04 pm |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek Director |
4,000,000 | $7.95 | $31,800,000 | 54,409,211 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-09 Exercise |
2023-06-13 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
43,893 | $5.12 | 198,582 (Direct) |
View |
| 2023-06-09 Exercise |
2023-06-13 9:31 pm |
N/A 2025-12-29 |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
43,893 | $0 | 198,582 (Direct) |
View |
| 2023-06-07 Exercise |
2023-06-09 9:32 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
299,585 | $3.85 | 31,605,849 (Direct) |
View |
| 2023-06-07 Exercise |
2023-06-09 9:32 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
299,585 | $0 | 31,605,849 (Direct) |
View |
| 2023-05-31 Other |
2023-06-02 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,711 | $9.08 | 286,751 (Direct) |
View |
| 2023-05-27 Exercise |
2023-05-31 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
170,464 | $6.4 | 2,284,781 (Direct) |
View |
| 2023-05-27 Exercise |
2023-05-31 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
53,281 | $0 | 2,284,781 (Direct) |
View |
| 2023-05-31 Other |
2023-05-31 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
30,266 | $9.09 | 2,284,781 (Direct) |
View |
| 2023-05-27 Exercise |
2023-05-31 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
1,222,787 | $6.4 | 63,350,919 (Direct) |
View |
| 2023-05-27 Exercise |
2023-05-31 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
382,203 | $0 | 63,350,919 (Direct) |
View |
| 2023-05-31 Other |
2023-05-31 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
189,947 | $9.09 | 63,350,919 (Direct) |
View |
| 2023-05-27 Exercise |
2023-05-31 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh See Remarks |
318,199 | $6.4 | 7,009,277 (Direct) |
View |
| 2023-05-27 Exercise |
2023-05-31 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh See Remarks |
99,458 | $0 | 7,009,277 (Direct) |
View |
| 2023-05-23 Other |
2023-05-25 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,557 | $9.58 | 200,139 (Direct) |
View |
| 2023-05-23 Other |
2023-05-25 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
18,972 | $9.58 | 1,057,225 (Direct) |
View |
| 2023-05-23 Other |
2023-05-25 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
15,671 | $9.58 | 16,298,537 (Direct) |
View |
| 2023-05-23 Exercise |
2023-05-25 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
415 | $3.85 | 16,298,537 (Direct) |
View |
| 2023-05-23 Exercise |
2023-05-25 9:30 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
415 | $0 | 16,298,537 (Direct) |
View |
| 2023-05-09 Exercise |
2023-05-11 9:33 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
238,724 | $3.85 | 16,298,952 (Direct) |
View |
| 2023-05-09 Exercise |
2023-05-11 9:33 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
238,724 | $0 | 16,298,952 (Direct) |
View |
| 2023-05-04 Exercise |
2023-05-08 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
150,044 | $3.85 | 32,460,790 (Direct) |
View |
| 2023-05-04 Exercise |
2023-05-08 9:30 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
150,044 | $0 | 32,460,790 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
288,989 | $3.85 | 49,058,218 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 9:30 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
288,989 | $0 | 49,058,218 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
77,736 | $3.85 | 1,715,656 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 9:30 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
77,736 | $0 | 1,715,656 (Direct) |
View |
| 2023-05-01 Other |
2023-05-03 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,667 | $8.61 | 288,418 (Direct) |
View |
| 2023-04-26 Exercise |
2023-04-28 9:35 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
172,264 | $3.85 | 2,898,294 (Direct) |
View |
| 2023-04-26 Exercise |
2023-04-28 9:35 pm |
N/A 2026-05-19 |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
230,788 | $0 | 2,898,294 (Direct) |
View |
| 2023-04-26 Exercise |
2023-04-28 9:35 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
58,524 | $3.97 | 2,898,294 (Direct) |
View |
| 2023-04-26 Exercise |
2023-04-28 9:35 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
222,243 | $3.85 | 49,803,751 (Direct) |
View |
| 2023-04-26 Exercise |
2023-04-28 9:35 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
222,243 | $0 | 49,803,751 (Direct) |
View |
| 2023-04-20 Option Award |
2023-04-24 9:28 pm |
N/A 2033-04-19 |
Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director |
118,578 | $0 | 118,578 (Direct) |
View |
| 2023-04-20 Tax Withholding |
2023-04-24 9:28 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
14,457 | $8.8 | 675,768 (Direct) |
View |
| 2023-04-20 Tax Withholding |
2023-04-24 9:28 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
19,375 | $8.8 | 1,057,225 (Direct) |
View |
| 2023-04-20 Tax Withholding |
2023-04-24 9:28 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,569 | $8.8 | 486,547 (Direct) |
View |
| 2023-04-20 Option Award |
2023-04-24 9:28 pm |
N/A 2033-04-19 |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
353,118 | $0 | 486,547 (Direct) |
View |
| 2023-04-20 Option Award |
2023-04-24 9:28 pm |
N/A 2033-04-19 |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
450,206 | $0 | 671,914 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
1,351 | $0 | 61,125 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
1,942 | $0 | 62,113 (Direct) |
View |
| 2023-03-29 Other |
2023-03-31 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,639 | $7.35 | 223,347 (Direct) |
View |
| 2023-03-23 Other |
2023-03-27 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
18,563 | $7.3 | 1,095,163 (Direct) |
View |
| 2023-03-23 Other |
2023-03-27 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
14,194 | $7.3 | 704,419 (Direct) |
View |
| 2023-03-23 Other |
2023-03-27 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
2,134 | $7.3 | 132,543 (Direct) |
View |
| 2023-02-22 Other |
2023-02-24 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,797 | $8.43 | 134,340 (Direct) |
View |
| 2023-02-22 Other |
2023-02-24 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
11,953 | $8.43 | 716,372 (Direct) |
View |
| 2023-02-22 Other |
2023-02-24 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
14,471 | $8.43 | 1,109,634 (Direct) |
View |
| 2023-01-24 Other |
2023-01-26 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
13,057 | $8.56 | 729,429 (Direct) |
View |
| 2023-01-24 Other |
2023-01-26 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
15,594 | $8.56 | 1,125,228 (Direct) |
View |
| 2023-01-24 Other |
2023-01-26 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,838 | $8.56 | 136,178 (Direct) |
View |